Verisk Analytics <VRSK.O>: Barclays cuts target price to $225 from $275
VRSK•Related News
Sarepta, Dyne sink after Novartis muscle disorder trial failure
SRPT•
Cognyte held annual shareholder meeting for fiscal 2027
CGNT•
Ionis Pharmaceuticals, Inc. <IONS.O>: BMO cuts target price to $54 from $61
IONS•
Hinge Health, Inc. <HNGE.N>: Stifel raises target price to $115 from $96
HNGE•
Boston Scientific says cyberattack likely to hurt 2026 sales, profit
BSX•